Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study

Coronavirus-disease-2019 (COVID-19) mRNA vaccination effectively reduces mortality and morbidity in cirrhotic patients, but the immunogenicity and safety of vaccination have been partially characterized. The study aimed to evaluate humoral response, predictive factors, and safety of mRNA-COVID-19 va...

Descripción completa

Detalles Bibliográficos
Autores principales: Biliotti, Elisa, Caioli, Alessandro, Sorace, Chiara, Lionetti, Raffaella, Milozzi, Eugenia, Taibi, Chiara, Visco Comandini, Ubaldo, Maggi, Fabrizio, Puro, Vincenzo, D’Offizi, Gianpiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215518/
https://www.ncbi.nlm.nih.gov/pubmed/37238990
http://dx.doi.org/10.3390/biomedicines11051320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215518/
https://www.ncbi.nlm.nih.gov/pubmed/37238990
http://dx.doi.org/10.3390/biomedicines11051320

Ejemplares similares